To hear about similar clinical trials, please enter your email below
Trial Title:
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
NCT ID:
NCT05761093
Condition:
Prostate Cancer
Conditions: Official terms:
Prostatic Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Summary:
The objective of this study is to examine the preference weightings in term of risk/
benefit attributes of treatment in physician and prostate cancer patients from different
stages of disease.
Criteria for eligibility:
Study pop:
300 consecutive patients with metastatic prostate cancer (150 mHSPC and 150 mCRPC) within
5 years will be recruited
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- aged 18 years or older,
- diagnosis of metastatic prostate cancer within 5 years,
- able to read and write,
- accepting and signing the informed consent
Exclusion Criteria:
- if patients are unable to complete the survey by themselves due to physical or
psychological reasons,
- deemed ineligible by treating physicians if patients are unable to complete the
survey by themselves due to physical or psychological reasons,
- deemed ineligible by treating physicians
Gender:
Male
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Prince of Wales Hospital
Address:
City:
Sha Tin
Country:
Hong Kong
Status:
Recruiting
Contact:
Last name:
Chi Fai NG, MD
Phone:
3505 2625
Email:
ngcf@surgery.cuhk.edu.hk
Start date:
September 7, 2022
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Chinese University of Hong Kong
Agency class:
Other
Source:
Chinese University of Hong Kong
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05761093
